MultiLing Corporation is a pioneering company established in 1988 that has become a benchmark in the field of advanced international translations. Their innovative approach integrates highly specialized translators, a centralized management system, terminology oversight, quality assurance, and proprietary technology, ensuring precise, specialized, and secure translations for global corporations with intricate requirements. Their unique model specifically caters to the patent, information technology, chemical, medical technology, biotechnology, and automotive sectors.
With the last investment of $10.30M in a Private Equity Round on 13 August 2013, MultiLing attracted Frontier Growth as an investor. This strategic investment is a testament to the company's viability and potential for growth, particularly in the Health Care industry.
